PMDA drug package insert
イリボー錠2.5μg
PMDA Prescription drug · アステラス製薬株式会社 · package insert Mar 22, 2021
Key facts
| Brand names | イリボー錠2.5μg, イリボー錠5μg |
|---|---|
| Nonproprietary names | ラモセトロン塩酸塩 |
| Companies | 製造販売／アステラス製薬株式会社 |
| Product type | Prescription drug |
| Therapeutic category | 下痢型過敏性腸症候群治療剤 |
| Therapeutic category codes | 872399 |
| YJ codes | 2399014F1026, 2399014F2022 |
| Approval numbers | 22000AMX01708, 22000AMX01709 |
| Package insert edition | 第2版 |
| Package insert date | Mar 22, 2021 |
| PMDA document key | 800126_2399014F1026_1 |
| PMDA company code | 800126 |
At a glance
- 1–9 Package insert revisions
- 10–99 Related PMDA documents
- None Safety communications
- Yes PMDA review report published
- No Risk management plan (RMP)
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About PMDA approved drugs and package inserts (Japan)
Japan's PMDA publishes the package insert (添付文書) of every prescription drug, OTC drug and regenerative medical product, with brand and nonproprietary names, YJ codes and approval numbers. Names appear in Japanese as published.
Source: Pharmaceuticals and Medical Devices Agency (PMDA), Japan, package insert database · Source date: